Clinical pharmacy services and solid organ transplantation: a literature review
- 11 December 2009
- journal article
- review article
- Published by Springer Nature in Pharmacy World & Science
- Vol. 32 (1) , 7-18
Abstract
Aim of the review Organ transplantation represents the therapy of choice for most types of end-stage organ failure, and post-transplant patient care warrants great attention. The aim of this study was to summarise the available evidence regarding the role and impact of clinical pharmacy services in the care of solid organ transplant patients. Methods A search of the literature was conducted using the MEDLINE, EMBASE and IPA databases to identify studies relevant to our investigation of the impact of clinical pharmacists’ interventions. Results Only five out of nineteen of the included studies were randomised controlled trials; eleven studies were descriptive, and three were before-after studies. Interventions performed in these studies consisted of routine clinical pharmacy services with a focus on identifying, resolving and preventing drug-related problems; clinical pharmacy services with a focus on therapeutic drug monitoring; and those with a focus on compliance enhancement and educational interventions. The number and type of interventions and the physicians’ acceptance rates were assessed in the majority of the included studies. Acceptance rates were generally above 95%, and most studies reported that clinical pharmacy services had a positive impact on the care of solid organ transplant patients. Positive perceptions of patients and health care professionals are also reported. In two of the studies, patients’ compliance rates and drug knowledge were assessed following counselling by a pharmacist. Dosing-related interventions were the most common interventions proposed. Immunosuppressants, cardiovascular drugs and antimicrobials were the drug classes most affected by the clinical pharmacists’ interventions. Conclusions High quality evidence that supports the benefit of clinical pharmacy services in the care of solid organ transplant patients is rare. Nevertheless, all of the included studies showed that clinical pharmacy services had a positive impact. Furthermore, all included studies showed that patients and physicians appreciated clinical pharmacists. The various outcome measures used in these studies were improved by interactions with clinical pharmacists. More randomised controlled trials are needed to contribute to the paucity of the existing evidence.Keywords
This publication has 23 references indexed in Scilit:
- Effects of Pharmaceutical Care Intervention by Clinical Pharmacists in Renal Transplant ClinicsTransplantation Proceedings, 2008
- The Impact of Clinical Pharmacists on Drug‐Related Problems and Clinical OutcomesBasic & Clinical Pharmacology & Toxicology, 2008
- 2006 National Clinical Pharmacy Services Survey: Clinical Pharmacy Services, Collaborative Drug Management, Medication Errors, and Pharmacy TechnologyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2008
- Clinical and economic outcomes of pharmaceutical services related to antibiotic use: a literature reviewPharmacy World & Science, 2007
- Clinical Pharmacists and Inpatient Medical CareArchives of internal medicine (1960), 2006
- Aportación del farmacéutico en el cuidado del paciente trasplantadoFarmacia Hospitalaria, 2006
- TransplantationsmedizinIntensivmedizin und Notfallmedizin, 2005
- The expanding role of the transplant pharmacist in the multidisciplinary practice of transplantationClinical Transplantation, 2004
- Evaluation de l’apport d’une consultation de pharmacie sur les connaissances des patients transplantés hépatiquesTherapies, 2003
- Roles of Pharmacist as a Member of the Liver Transplant team in Controlling Tacrolimus whole Blood Concentrations and Monitoring Adverse Drug Events such as Convulsion.Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 2002